Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Pasta

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2024
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 8, 2025
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Maria Corina Plaz Torres, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World StudyDaria Maniero, Matteo Ghisa, Alessandro Bruschi, et al.
Clinical and Translational Gastroenterology|May 23, 2025
Clinical and Endoscopic-Histological Features of Multifocal and Corpus-Restricted Atrophic Gastritis Patients With Non-Cardia Gastric Cancer or Dysplasia: A Multicenter, Cross-Sectional StudyEdith Lahner, Bruno Annibale, Emanuele Dilaghi, et al.
Digestive Diseases and Sciences|May 3, 2025
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune HepatitisAndrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, et al.
Neurogastroenterology and Motility|July 16, 2026
Inter-Observer Variability of Gerd-Related Metrics on High-Resolution Manometry and Calculation of the Milan ScoreMarco Sozzi, Stefano Siboni, Andres R Latorre-Rodriguez, et al.
Liver Cancer|April 22, 2026
Comparative Efficacy of Initial Treatment Strategies in Patients with Transarterial Chemoembolisation-Unsuitable Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
United European Gastroenterology Journal|June 21, 2025
Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and MotilityAmir Mari, Francesco Calabrese, Andrea Pasta, et al.
Intestinal Research|September 29, 2025
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world studyAntonio Tursi, Giammarco Mocci, Francesco Costa, et al.
Advances in Therapy|May 9, 2026
Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort StudyAntonio Tursi, Andrea Pasta, Walter Elisei, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2024
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 8, 2025
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Maria Corina Plaz Torres, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World StudyDaria Maniero, Matteo Ghisa, Alessandro Bruschi, et al.
Clinical and Translational Gastroenterology|May 23, 2025
Clinical and Endoscopic-Histological Features of Multifocal and Corpus-Restricted Atrophic Gastritis Patients With Non-Cardia Gastric Cancer or Dysplasia: A Multicenter, Cross-Sectional StudyEdith Lahner, Bruno Annibale, Emanuele Dilaghi, et al.
Digestive Diseases and Sciences|May 3, 2025
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune HepatitisAndrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, et al.
Neurogastroenterology and Motility|July 16, 2026
Inter-Observer Variability of Gerd-Related Metrics on High-Resolution Manometry and Calculation of the Milan ScoreMarco Sozzi, Stefano Siboni, Andres R Latorre-Rodriguez, et al.
Liver Cancer|April 22, 2026
Comparative Efficacy of Initial Treatment Strategies in Patients with Transarterial Chemoembolisation-Unsuitable Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
United European Gastroenterology Journal|June 21, 2025
Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and MotilityAmir Mari, Francesco Calabrese, Andrea Pasta, et al.
Intestinal Research|September 29, 2025
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world studyAntonio Tursi, Giammarco Mocci, Francesco Costa, et al.
Advances in Therapy|May 9, 2026
Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort StudyAntonio Tursi, Andrea Pasta, Walter Elisei, et al.
Pageof 9